These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 19029628)

  • 21. Nodal signals to Smads through Cripto-dependent and Cripto-independent mechanisms.
    Yeo C; Whitman M
    Mol Cell; 2001 May; 7(5):949-57. PubMed ID: 11389842
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Role of Cripto-1 protein in development and target therapy of breast cancer].
    Lei T; Guo XJ; Fu L
    Zhonghua Bing Li Xue Za Zhi; 2010 Jan; 39(1):66-8. PubMed ID: 20388407
    [No Abstract]   [Full Text] [Related]  

  • 23. Nodal-dependent Cripto signaling promotes cardiomyogenesis and redirects the neural fate of embryonic stem cells.
    Parisi S; D'Andrea D; Lago CT; Adamson ED; Persico MG; Minchiotti G
    J Cell Biol; 2003 Oct; 163(2):303-14. PubMed ID: 14581455
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cripto-1 alters keratinocyte differentiation via blockade of transforming growth factor-beta1 signaling: role in skin carcinogenesis.
    Shukla A; Ho Y; Liu X; Ryscavage A; Glick AB
    Mol Cancer Res; 2008 Mar; 6(3):509-16. PubMed ID: 18337457
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nodal-dependant Cripto signaling in ES cells: from stem cells to tumor biology.
    Minchiotti G
    Oncogene; 2005 Aug; 24(37):5668-75. PubMed ID: 16123800
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression of nodal signalling components in cycling human endometrium and in endometrial cancer.
    Papageorgiou I; Nicholls PK; Wang F; Lackmann M; Makanji Y; Salamonsen LA; Robertson DM; Harrison CA
    Reprod Biol Endocrinol; 2009 Oct; 7():122. PubMed ID: 19874624
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cripto: a tumor growth factor and more.
    Adamson ED; Minchiotti G; Salomon DS
    J Cell Physiol; 2002 Mar; 190(3):267-78. PubMed ID: 11857442
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Activation of a Nodal-independent signaling pathway by Cripto-1 mutants with impaired activation of a Nodal-dependent signaling pathway.
    Bianco C; Mysliwiec M; Watanabe K; Mancino M; Nagaoka T; Gonzales M; Salomon DS
    FEBS Lett; 2008 Dec; 582(29):3997-4002. PubMed ID: 19013461
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Embryonic morphogen nodal promotes breast cancer growth and progression.
    Quail DF; Zhang G; Walsh LA; Siegers GM; Dieters-Castator DZ; Findlay SD; Broughton H; Putman DM; Hess DA; Postovit LM
    PLoS One; 2012; 7(11):e48237. PubMed ID: 23144858
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A GPI processing phospholipase A2, PGAP6, modulates Nodal signaling in embryos by shedding CRIPTO.
    Lee GH; Fujita M; Takaoka K; Murakami Y; Fujihara Y; Kanzawa N; Murakami KI; Kajikawa E; Takada Y; Saito K; Ikawa M; Hamada H; Maeda Y; Kinoshita T
    J Cell Biol; 2016 Dec; 215(5):705-718. PubMed ID: 27881714
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cripto-1: an oncofetal gene with many faces.
    Bianco C; Strizzi L; Normanno N; Khan N; Salomon DS
    Curr Top Dev Biol; 2005; 67():85-133. PubMed ID: 15949532
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cripto: a novel epidermal growth factor (EGF)-related peptide in mammary gland development and neoplasia.
    Salomon DS; Bianco C; De Santis M
    Bioessays; 1999 Jan; 21(1):61-70. PubMed ID: 10070255
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Requirement of glycosylphosphatidylinositol anchor of Cripto-1 for trans activity as a Nodal co-receptor.
    Watanabe K; Hamada S; Bianco C; Mancino M; Nagaoka T; Gonzales M; Bailly V; Strizzi L; Salomon DS
    J Biol Chem; 2007 Dec; 282(49):35772-86. PubMed ID: 17925387
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nodal/Cripto signaling in fetal male germ cell development: implications for testicular germ cell tumors.
    Spiller CM; Bowles J; Koopman P
    Int J Dev Biol; 2013; 57(2-4):211-9. PubMed ID: 23784832
    [TBL] [Abstract][Full Text] [Related]  

  • 35. New Anti-Nodal Monoclonal Antibodies Targeting the Nodal Pre-Helix Loop Involved in Cripto-1 Binding.
    Focà A; Sanguigno L; Focà G; Strizzi L; Iannitti R; Palumbo R; Hendrix MJ; Leonardi A; Ruvo M; Sandomenico A
    Int J Mol Sci; 2015 Sep; 16(9):21342-62. PubMed ID: 26370966
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cripto forms a complex with activin and type II activin receptors and can block activin signaling.
    Gray PC; Harrison CA; Vale W
    Proc Natl Acad Sci U S A; 2003 Apr; 100(9):5193-8. PubMed ID: 12682303
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Enhancement of Notch receptor maturation and signaling sensitivity by Cripto-1.
    Watanabe K; Nagaoka T; Lee JM; Bianco C; Gonzales M; Castro NP; Rangel MC; Sakamoto K; Sun Y; Callahan R; Salomon DS
    J Cell Biol; 2009 Nov; 187(3):343-53. PubMed ID: 19948478
    [TBL] [Abstract][Full Text] [Related]  

  • 38. ErbB/EGF signaling and EMT in mammary development and breast cancer.
    Hardy KM; Booth BW; Hendrix MJ; Salomon DS; Strizzi L
    J Mammary Gland Biol Neoplasia; 2010 Jun; 15(2):191-9. PubMed ID: 20369376
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cripto-1 ablation disrupts alveolar development in the mouse mammary gland through a progesterone receptor-mediated pathway.
    Klauzinska M; McCurdy D; Rangel MC; Vaidyanath A; Castro NP; Shen MM; Gonzales M; Bertolette D; Bianco C; Callahan R; Salomon DS; Raafat A
    Am J Pathol; 2015 Nov; 185(11):2907-22. PubMed ID: 26429739
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression of transforming growth factor alpha, amphiregulin and cripto-1 in human breast carcinomas.
    Qi CF; Liscia DS; Normanno N; Merlo G; Johnson GR; Gullick WJ; Ciardiello F; Saeki T; Brandt R; Kim N
    Br J Cancer; 1994 May; 69(5):903-10. PubMed ID: 8180021
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.